EUCRATES BIOMEDICAL ACQU COR's ticker is EUCR and the CUSIP is G3141W106. A total of 6 filers reported holding EUCRATES BIOMEDICAL ACQU COR in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $6,529,000 | -4.1% | 650,920 | -5.3% | 0.06% | +13.7% |
| Q2 2022 | $6,807,000 | +34.8% | 687,528 | +34.1% | 0.05% | -25.0% |
| Q1 2022 | $5,048,000 | +19.3% | 512,528 | +18.3% | 0.07% | +58.1% |
| Q4 2021 | $4,230,000 | -0.2% | 433,382 | 0.0% | 0.04% | -24.6% |
| Q3 2021 | $4,238,000 | -0.7% | 433,382 | 0.0% | 0.06% | +9.6% |
| Q2 2021 | $4,267,000 | +8.8% | 433,382 | +9.3% | 0.05% | +8.3% |
| Q1 2021 | $3,921,000 | -51.2% | 396,480 | -50.4% | 0.05% | +11.6% |
| Q4 2020 | $8,040,000 | – | 799,998 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SkyView Investment Advisors, LLC | 71,773 | $717 | 0.22% |
| EcoR1 Capital, LLC | 200,000 | $1,998,000 | 0.06% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| UBS Group AG | 3,483 | $34,795 | 0.00% |
| Tower Research Capital LLC (TRC) | 657 | $7 | 0.00% |
| DEUTSCHE BANK AG\ | 21,923 | $219,011 | 0.00% |